Associated Papers
Cell-Free DNA Profiling to Discover Mechanisms of Exceptional Response to Cabozantinib Plus Panitumumab in a Patient With Treatment Refractory Metastatic Colorectal Cancer.
Jia J et al.
Frontiers in Oncology, 2018
Select a paper to view details